<?xml version="1.0" encoding="UTF-8"?>
<svg height="870.031005859375" width="672.0029907226562" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 0.05999799817800522 826.072021484375 L 22.619997024536133 826.072021484375 L 22.619997024536133 826.35546875 L 0.05999799817800522 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 837.4110107421875 L 33.959449768066406 837.4110107421875 L 33.959449768066406 860.031005859375 L 33.67599868774414 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 837.4110107421875 L 628.2703857421875 837.4110107421875 L 628.2703857421875 860.031005859375 L 627.9869995117188 860.031005859375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 826.072021484375 L 662.0029907226562 826.072021484375 L 662.0029907226562 826.35546875 L 639.3259887695312 826.35546875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 639.3259887695312 33.731998443603516 L 662.0029907226562 33.731998443603516 L 662.0029907226562 34.015480041503906 L 639.3259887695312 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 627.9869995117188 0.0 L 628.2703857421875 0.0 L 628.2703857421875 22.677000045776367 L 627.9869995117188 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 33.67599868774414 0.0 L 33.959449768066406 0.0 L 33.959449768066406 22.677000045776367 L 33.67599868774414 22.677000045776367 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 0.05999799817800522 33.731998443603516 L 22.619997024536133 33.731998443603516 L 22.619997024536133 34.015480041503906 L 0.05999799817800522 34.015480041503906 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text x="89.348,91.754,95.878,98.284,101.593,106.958,108.975,112.24,115.505,119.241,122.118,126.242,128.25900000000001,133.112,138.866,140.883,145.755,153.227,156.963,159.84,163.964,165.982,167.999,170.016,174.893,180.647,182.664,187.536,192.049,196.173,199.05,201.456,205.58,207.597,211.722,214.128,216.534,218.551,223.42,227.933,229.95,234.814,238.079,240.485,245.358,249.094,251.112,253.129,257.944,261.68,263.697,266.962,270.228,273.963,277.228,282.093,284.97,288.235,291.112,294.377,297.642,300.048,302.161,306.286,310.41,313.28700000000003,318.091,321.827,325.951" y="37.76400000000001" svg_rhmargin="330.075" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[3] Rizzardi G, Marulli G, Bortolotti L, et al. Sleeve resections and</text>
  <text x="101.594,105.718,108.595,112.719,116.843,120.109,124.233,128.358,132.482,134.499,138.235,141.112,143.518,145.535,148.79999999999998,151.082,155.207,158.083,162.208,165.473,168.738,172.863,176.987,179.936,183.201,186.078,188.326,190.344,194.469,196.716,199.122,202.858,206.983,209.0,212.265,216.001,218.018,220.242,223.507,226.772,230.897,233.303,236.179,239.915,241.932,244.221,247.486,251.222,254.099,257.364,259.382,263.506,267.63,269.731,273.856,276.08,278.486,282.611,288.752,292.877,297.001,299.878,302.755,304.772,307.032,311.934,316.058,320.182,323.059,326.795" y="46.721000000000004" svg_rhmargin="330.06" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">bronchoplastic procedures in typical central carcinoid tumours. Thorac</text>
  <text x="101.594,106.958,110.694,113.571,117.695,119.713,123.837,127.573,131.309,134.186,137.451,139.972,143.708,147.832,150.709,154.445,156.978,161.103,165.227,169.352,173.476,175.493,179.618,183.742,185.76,189.884" y="55.678" svg_rhmargin="194.008" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cardiovasc Surg 2008;56:42</text>
  <text x="194.059" y="55.678" svg_rhmargin="197.795" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="197.801,201.926" y="55.678" svg_rhmargin="203.943" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="89.348,91.754,95.878,98.284,101.593,109.065,113.189,117.313,120.19,123.455,126.026,133.497,135.514,138.044,142.168,145.045,148.31,150.328,154.452,157.717,160.594,164.32999999999998,166.899,171.412,173.429,175.969,180.482,182.499,185.376,189.5,193.236,198.989,201.006,203.575,211.048,213.065,215.651,218.916,221.322,223.815,227.551,229.568,231.585,234.189,238.313,244.067,249.82,252.226,256.35,260.863,265.765,268.315,270.333,276.475,280.211,283.947,285.964,290.088,293.824,296.433,298.451,302.576,305.107,309.232,312.968,315.374,317.391,320.656,324.781,327.187" y="64.63599999999997" svg_rhmargin="330.064" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[4] Moore W, Freiberg E, Bishawi M, et al. FDG-PET imaging in patients</text>
  <text x="101.594,107.347,109.364,111.77,115.895,118.374,122.498,126.623,128.64,134.782,138.906,143.031,146.767,149.722,153.458,155.958,159.224,162.959,165.836,169.101,171.119,175.243,179.368,181.385,185.51,188.044,190.45,194.574,200.716,204.84,207.717,209.734,212.249,217.614,219.632,221.649,225.774,228.293,234.435,238.559,241.824,243.841,246.377,253.849,257.115,261.24,263.781,267.905,272.03,276.154,280.279,282.296,286.42,290.545,292.562,296.687,300.811" y="73.59299999999996" svg_rhmargin="304.935" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">with pulmonary carcinoid tumor. Clin Nucl Med 2013;38:501</text>
  <text x="305.007" y="73.59299999999996" svg_rhmargin="308.743" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="308.692,312.817" y="73.59299999999996" svg_rhmargin="314.834" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text svg_rhmargin="240.09" x="89.348,91.754,95.878,98.284,101.593,106.958,111.082,113.099,116.365,120.49,122.568,128.709,130.726,132.772,138.525,141.402,145.526,149.651,153.775,157.9,161.165,164.041,167.777,169.846,175.988,178.005,180.05,182.927,186.663,189.928,194.053,198.247,201.124,204.001,208.125,212.25,214.291,220.515,222.53199999999998,224.552,227.818,230.22400000000002,232.319,236.055,238.073,240.09" y="79.26300000000003" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[5] Uhlén N, Grundberg O, Jacobsson H, et al. </text>
  <text x="242.135,245.228" y="79.26300000000003" svg_rhmargin="248.321" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:4.98px;font-style:NORMAL;font-weight:normal;">18</text>
  <text x="248.315,252.439,254.845,258.97,264.723,270.476,272.521,276.646,281.159,286.06,288.078,293.442,298.344,300.412,304.536,306.554,310.29,314.026,318.15,322.351,325.227,327.245" y="82.55100000000004" svg_rhmargin="330.122" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">F-FDG PET/CT diagnosis</text>
  <text x="101.594,105.719,108.125,111.005,115.129,118.006,122.13,126.255,129.52,133.644,137.769,141.893,146.018,148.035,154.258,158.383,162.507,166.243,169.12,172.856,175.744,179.009,182.745,185.621,188.886,190.904,195.028,199.153,201.17,205.295,208.172,211.061,214.796,218.062,220.938,223.815,228.01,230.887,233.736,237.86,241.985,244.002,250.144,254.268,258.393,262.129,265.085,268.82099999999997,271.661,275.786,279.522,285.663,289.399,292.352,294.758,298.883,305.024,308.76,311.637,313.654,316.558,321.923,323.94,325.957" y="91.56500000000005" svg_rhmargin="330.081" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">of bronchopulmonary carcinoids versus pulmonary hamartomas. Clin</text>
  <text x="101.594,107.736,111.86,115.126,117.143,119.621,127.094,130.359,134.484,137.025,141.15,145.274,149.399,153.523,155.541,159.665,163.789,165.807,169.931,174.056" y="100.52200000000005" svg_rhmargin="178.18" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Nucl Med 2016;41:263</text>
  <text x="178.243" y="100.52200000000005" svg_rhmargin="181.979" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="181.985,186.11" y="100.52200000000005" svg_rhmargin="188.127" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">7.</text>
  <text x="89.349,91.755,95.88,98.286,101.594,106.959,109.701,113.825,117.561,120.699,123.576,125.405,129.14,131.15699999999998,132.944,137.457,141.448,144.713,148.838,150.632,155.996,161.233,163.25,165.088,169.602,171.619,175.576,181.718,184.595,186.857,190.122,192.14,196.265,198.025,204.167,211.518,213.535,215.373,218.638,221.044,222.799,226.535,228.553,230.57,232.323,237.688,240.564,243.82899999999998,245.588,249.714,252.12,253.866,255.883,260.007,262.256,265.521,269.257,271.95,275.686,278.091,281.247,285.372,287.2,291.325,296.951,302.704,304.548,308.672,313.051,317.953,319.97,325.182" y="109.48000000000002" svg_rhmargin="330.084" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[6] Krüger S, Buck AK, Blumstein NM, et al. Use of integrated FDG PET/CT</text>
  <text x="101.595,103.612,109.645,113.381,117.117,118.942,123.067,126.803,128.069,130.086,134.211,135.382,139.507,143.631,145.53,151.672,155.677,159.802,163.538,166.221,169.957,171.267,174.532,178.127,181.004,184.269,186.177,190.302,194.284,196.301,200.426,201.654,204.06,208.061,214.202,218.327,222.289,225.166,228.042,230.059,231.246,234.12300000000002,235.385,237.791,241.915,244.172,247.437,250.314,254.439,255.623,263.095,266.224,270.349,271.667,275.792,279.774,283.899,288.023,289.865,293.989,298.114,302.109,304.127,308.119,312.243" y="118.43700000000001" svg_rhmargin="316.367" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">imaging in pulmonary carcinoid tumours. J Intern Med 2006;260:545</text>
  <text x="316.29" y="118.43700000000001" svg_rhmargin="320.026" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="319.975,324.099,328.082" y="118.43700000000001" svg_rhmargin="330.099" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">50.</text>
  <text x="89.349,91.755,95.88,98.286,101.594,106.107,110.232,113.497,117.621,120.886,125.011,127.217,131.342,133.359,135.55,140.452,143.329,146.662,150.398,152.415,154.432,158.16799999999998,160.381,166.134,168.15099999999998,170.358,175.723,178.988,181.864,185.6,188.477,190.494,194.619,196.888,202.253,204.26999999999998,206.468,209.733,212.139,214.348,218.084,220.101,222.118,224.325,228.45,232.574,236.698,239.964,242.37,244.387,248.588,252.712,256.448,258.465,260.663,262.68,268.822,272.558,276.294,278.311,282.436,286.17199999999997,288.383,291.648,295.384,299.12,301.137,305.333,309.069,311.475,313.492,317.617,321.742,323.927,325.945" y="127.394" svg_rhmargin="330.069" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[7] Lococo F, Treglia G, Cesario A, et al. Functional imaging evaluation in</text>
  <text x="101.595,104.001,108.125,111.39,115.143,119.269,122.534,124.94,128.205,131.47,133.876,135.893,140.018,144.142,146.159,149.951,154.075,156.093,159.829,163.564,167.689,171.813,174.69,176.707,179.584,181.601,185.381,189.117,193.241,197.366,201.14,205.265,207.282,210.159,212.565,216.689,218.706,222.831,226.567,228.584,231.849,235.607,239.731,241.749,244.155,246.56,249.826,252.702,255.967,260.092,262.498,264.515,268.251,270.657,272.794,276.918,281.043,284.756,288.88,291.286,295.073,299.198,303.322,305.34,311.481,315.606,319.73,323.466,326.343" y="136.351" svg_rhmargin="330.079" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">the detection, diagnosis, and histologic differentiation of pulmonary</text>
  <text x="101.595,105.719,108.984,113.109,115.986,120.11,123.375,127.5,131.624,135.748,139.014,141.89,143.908,148.032,151.297,153.861,156.267,160.391,166.533,170.657,173.534,176.411,178.428,180.958,185.86,189.984,194.108,196.985,200.721,203.986,206.524,210.26,214.385,217.261,220.99699999999999,223.474,228.839,230.856,232.874,236.999,239.518,243.642,247.766,251.891,256.015,258.033,262.157,266.282,268.371,272.496,276.62" y="145.365" svg_rhmargin="280.744" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">neuroendocrine tumors. Thorac Surg Clin 2014;24:285</text>
  <text x="280.743" y="145.365" svg_rhmargin="284.479" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="284.485,288.61,292.734" y="145.365" svg_rhmargin="294.751" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">92.</text>
  <text x="89.349,91.755,95.88,98.286,101.594,104.471,106.488,110.613,114.737,118.473,120.49,122.739,127.641,129.65800000000002,131.866,137.231,141.355,147.569,151.305,154.18200000000002,156.412,161.777,163.79399999999998,165.993,171.358,174.623,178.747,182.943,184.96,187.366,191.102,193.978,197.714,203.856,207.592,211.717,213.951,218.464,220.481,222.738,226.003,228.409,230.675,234.411,236.428,238.445,240.652,246.017,250.141,252.158,255.42299999999997,257.715,261.84,264.246,266.445,268.851,272.975,277.1,279.506,285.259,288.995,291.401,297.154,303.406,308.307,313.672,318.574,324.715" y="154.32299999999998" svg_rhmargin="330.08" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[8] Jindal T, Kumar A, Venkitaraman B, et al. Role of (68)Ga-DOTATOC</text>
  <text x="101.595,105.719,110.232,115.134,117.151,122.516,127.418,130.279,132.296,136.421,139.236,141.642,145.767,149.03199999999998,151.822,155.087,158.823,162.559,164.576,168.701,172.436,174.842,176.86,181.073,185.198,187.99,192.114,194.52,197.344,201.469,204.346,206.363,212.505,216.241,219.117,222.85299999999998,225.689,229.813,233.938,235.955,242.097,246.221,250.346,254.082,257.037,260.77299999999997,263.557,266.822,270.558,273.435,276.7,278.718,282.842,286.966,289.067,293.191,296.068,298.085,300.915,306.28,310.404,313.281,316.546,320.282,324.407,327.218" y="163.27999999999997" svg_rhmargin="330.095" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PET/CT in the evaluation of primary pulmonary carcinoids. Korean J</text>
  <text x="101.595,104.002,108.127,110.533,113.799,116.677,120.802,123.31,130.783,134.049,138.174,140.659,144.783,148.909,153.034,157.159,159.255,163.38,167.505,169.523,173.648,177.774" y="172.23699999999997" svg_rhmargin="181.898" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Intern Med 2010;25:386</text>
  <text x="181.872" y="172.23699999999997" svg_rhmargin="185.608" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="185.614,189.739,193.864" y="172.23699999999997" svg_rhmargin="195.881" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">91.</text>
  <text x="89.35,91.756,95.88,98.286,101.595,105.331,107.737,111.002,113.408,117.144,121.268,123.285,127.275,132.64,134.65699999999998,138.67,142.794,145.671,149.407,153.531,156.797,160.062,162.938,166.204,170.328,173.593,175.999,178.405,182.53,186.572,191.936,193.953,197.909,204.051,207.316,210.193,213.458,215.475,219.508,222.385,224.402,228.352,231.617,234.023,238.046,241.782,243.799,245.816,249.78,252.186,256.31,258.716,261.982,265.717,268.594,272.33,274.736,278.001,282.126,286.174,290.298,296.051,301.805,304.211,308.335,312.848,317.75,319.767,325.132" y="181.19399999999996" svg_rhmargin="330.034" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[9] Stefani A, Franceschetto A, Nesci J, et al. Integrated FDG-PET/CT</text>
  <text x="101.596,103.613,109.755,113.491,117.227,119.244,123.368,127.104,130.393,132.411,135.288,138.557,142.682,145.558,148.823,151.229,155.354,157.371,160.665,162.683,166.808,170.076,172.482,176.607,179.87199999999999,183.115,186.851,190.976,195.1,197.977,202.162,205.898,209.163,213.288,216.561,218.967,223.092,226.369,229.634,233.37,236.246,239.512,241.529,245.653,249.778,251.795,255.92,259.192,261.598,265.722,271.864,275.988,278.865,281.742,285.042,289.166,291.572,294.849,297.255,301.38,304.645,307.944,309.962,314.086,318.211,321.946,323.963,327.219" y="190.15099999999995" svg_rhmargin="330.096" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">imaging is useful in the approach to carcinoid tumors of the lung. J</text>
  <text x="101.596,106.96,110.696,113.573,117.697,119.715,123.839,126.245,130.37,134.494,137.371,141.107,144.37199999999999,146.89,150.626,154.75,157.627,161.363,163.896,168.021,172.145,176.27,180.394,182.411,186.536,188.553,192.678,196.802,200.927" y="199.10900000000004" svg_rhmargin="202.944" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Cardiothorac Surg 2013;8:223.</text>
  <text x="85.211,87.617,91.742,95.866,98.272,101.595,106.497,110.233,112.639,115.904,117.92099999999999,120.36,124.873,126.89,129.374,135.515,138.781,144.922,148.188,152.313,154.77,160.913,162.93,165.429,171.182,175.306,179.431,182.696,185.961,190.086,192.526,197.891,199.908,202.39,205.655,208.061,210.497,214.233,216.25,218.267,220.758,224.883,229.007,233.131,235.537,239.662,245.415,251.168,253.638,257.762,262.275,267.177,269.194,274.559,279.461,281.925,284.802,288.538,291.414,294.68,296.697,300.433,302.9,307.025,309.901,314.026,317.761,319.85,323.975,327.24" y="208.12300000000005" svg_rhmargin="330.117" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[10] Tatci E, Ozmen O, Gokcek A, et al. 18F-FDG PET/CT rarely provides</text>
  <text x="101.596,105.332,109.456,113.58,115.598,118.004,120.021,124.146,128.27,132.006,134.023,136.685,138.703,142.827,145.233,149.358,152.234,158.376,162.195,164.601,166.618,170.743,174.868,177.501,181.626,184.032,188.156,191.422,194.299,197.002,199.408,203.533,207.269,211.394,214.066,218.19,221.067,223.084,229.226,232.962,235.838,239.57399999999998,242.24,244.645,248.77,254.912,259.036,261.913,264.575,268.699,271.965,274.438,277.704,280.969,283.375,285.392,289.517,293.642,296.32,298.338,302.463,305.108,309.232,312.968,315.374,317.392,320.657,324.781,327.187" y="217.08000000000004" svg_rhmargin="330.064" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">additional information other than primary tumor detection in patients</text>
  <text x="101.596,107.349,109.366,111.772,115.897,118.376,122.5,126.625,128.642,134.784,138.908,143.033,146.769,149.725,153.46099999999998,155.96,159.226,162.962,165.838,169.103,171.121,175.245,179.37,181.387,185.512,188.046,190.452,194.576,200.718,204.842,207.719,210.596,212.613,215.143,220.508,224.632,228.757,231.299,236.201,240.325,244.45,247.326,251.062,254.327,256.809,264.281,267.546,271.671,274.212,278.337,282.461,286.585,290.71,292.727,296.852,298.869,302.993,307.118" y="226.03700000000003" svg_rhmargin="311.242" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">with pulmonary carcinoid tumors. Ann Thorac Med 2014;9:227</text>
  <text x="311.301" y="226.03700000000003" svg_rhmargin="315.037" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="315.043,319.168,323.292" y="226.03700000000003" svg_rhmargin="325.309" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">31.</text>
  <text x="85.211,87.617,91.742,95.866,98.272,101.595,106.96,110.099,114.224,118.348,120.19,122.596,126.332,129.09,132.826,138.841,142.577,146.702,147.798,152.311,154.328,155.395,160.76,164.352,167.229,171.353,175.35,179.086,183.06,185.077,187.483,191.45,193.46699999999998,194.625,198.361,200.378,201.428,206.793,210.917,216.904,220.64,223.517,224.614,229.979,231.996,233.061,236.326,238.732,239.807,243.543,245.561,247.578,248.594,253.959,258.083,259.932,263.197,264.354,268.478,270.884,271.95,276.075,280.199,285.783,289.519,291.925,297.517,303.659,308.561,313.787,318.689,324.831" y="234.99400000000003" svg_rhmargin="330.196" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[11] Venkitaraman B, Karunanithi S, Kumar A, et al. Role of 68Ga-DOTATOC</text>
  <text x="101.596,105.72,110.099,115.001,116.902,122.266,127.168,128.41,130.427,134.552,135.723,137.74,141.865,143.716,146.122,148.025,151.761,153.778,154.997,158.262,161.998,165.542,167.559,171.683,175.292,177.698,179.6,183.725,187.85,189.068,193.192,195.598,196.778,200.903,204.638,206.869,208.886,212.027,216.152,218.558,221.435,222.628,228.382,230.281,232.687,236.812,237.991,240.868,244.992,247.742,251.867,254.999,258.264,260.554,263.82,267.945,269.172,273.297,276.031,280.156,284.28,287.369,291.494,295.618,299.614,303.738,305.623,311.765,315.89,319.852,323.588,326.464" y="243.95100000000002" svg_rhmargin="330.2" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PET/CT in initial evaluation of patients with suspected bronchopulmonary</text>
  <text x="101.596,104.861,108.455,111.332,114.597,116.449,120.573,124.698,126.596,130.721,132.738,134.874,139.387,143.378,146.255,148.424,151.30100000000002,153.526,159.669,163.674,166.94,168.957,171.101,178.573,181.702,185.827,188.052,195.524,199.503,201.51999999999998,203.755,206.161,212.202,215.938,219.674,221.499,225.624,229.35999999999999,231.477,235.602,239.726,243.722,247.846,249.731,253.856,257.98,259.822,263.947,268.071" y="252.909" svg_rhmargin="272.195" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinoid. Eur J Nucl Med Mol Imaging 2014;41:856</text>
  <text x="272.07" y="252.909" svg_rhmargin="275.806" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="275.755,279.88,283.863" y="252.909" svg_rhmargin="285.88" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">64.</text>
  <text x="85.211,87.617,91.742,95.866,98.272,101.595,106.96,111.084,114.82,117.697,121.433,123.45,127.899,133.263,135.28,139.747,144.26,147.525,151.649,155.774,159.898,161.915,164.009,167.274,171.399,175.524,179.939,183.675,185.692,190.143,195.897,199.162,202.898,207.094,211.218,214.095,217.36,219.377,222.25400000000002,226.708,232.461,234.478,238.953,242.218,244.624,249.1,252.836,254.853,256.87,261.289,265.413,268.679,271.555,273.961,278.086,280.962,287.196,290.932,295.056,298.321,301.586,306.017,310.141,312.547,317.014,319.42,323.545,327.669" y="261.923" svg_rhmargin="330.075" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[12] Abgral R, Leboulleux S, Déandreis D, et al. Performance of (18)</text>
  <text x="101.596" y="270.88" svg_rhmargin="105.72" style="fill:#171615;font-family:HPMFFO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="105.734,109.859,113.983,116.86,120.984,125.109,128.374,132.498,136.623,140.359,144.094,146.112,150.236,153.501,157.626,160.503,163.768,166.174,170.298,174.423,177.299,179.428,181.834,184.71,188.835,192.96,197.286,200.551,206.693,208.71,211.587,214.463,216.481,220.698,224.823,229.145,231.55,235.675,241.817,245.941,249.677,252.554,256.29,260.493,264.618,268.354,272.682,276.418,280.542,284.667,289.065,291.942,296.066,302.208,305.944,308.35,312.474,315.351,317.757,321.493,323.899,325.916" y="270.88" svg_rhmargin="330.04" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">uorodeoxyglucose-positron emission tomography and somatostatin</text>
  <text x="101.596,104.472,107.737,111.003,114.268,118.392,120.798,124.923,127.8,131.017,133.893,137.158,139.176,143.3,145.706,147.724,151.459,154.336,158.072,162.196,166.321,170.057,173.306,175.712,179.837,182.714,185.948,190.072,192.09,195.826,199.951,203.125,208.489,210.507,214.631,218.756,222.002" y="279.837" svg_rhmargin="224.408" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">receptor scintigraphy for high Ki67 (</text>
  <text x="224.392" y="279.837" svg_rhmargin="229.45" style="fill:#171615;font-family:HPMFEG+AdvOTb0c9bf5d+22;font-size:7.47px;font-style:NORMAL;font-weight:normal;">≥</text>
  <text x="229.494,233.619,237.743,245.215,247.621,250.809,256.562,259.827,261.845,263.862,266.268,270.393,272.41,274.816,277.222,280.487,283.364,286.749,290.874,293.279,295.297,299.033,301.439,304.704,308.829,312.032,315.297,319.422,323.546,327.671" y="279.837" svg_rhmargin="330.077" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">10%) well-differentiated endo-</text>
  <text x="101.596,104.861,107.737,109.755,113.879,117.144,119.623,122.888,126.624,129.501,132.766,134.783,138.908,143.032,149.271,153.00699999999998,155.507,158.384,160.789,164.525,168.261,170.279,174.403,178.139,180.156,182.661,185.538,188.047,193.412,195.429,197.447,201.572,204.091,208.604,212.728,216.853,220.977,224.242,227.119,229.136,233.261,237.385,239.402,241.959,249.43,252.696,255.102,258.837,262.962,265.484,269.609,273.733,277.858,281.982,283.999,288.124,292.248,294.266,298.39,302.514" y="288.794" svg_rhmargin="306.638" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">crine carcinoma staging. J Clin Endocrinol Metab 2011;96:665</text>
  <text x="306.709" y="288.794" svg_rhmargin="310.445" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="310.451,314.576,318.702" y="288.794" svg_rhmargin="320.719" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">71.</text>
  <text x="85.211,87.617,91.742,95.866,98.272,101.595,105.72,109.456,112.333,116.458,118.773,124.137,131.609,133.626,135.893,141.646,145.77,149.895,152.219,155.096,162.568,164.585,166.901,171.414,174.68,177.945,180.28,186.505,189.382,191.399,193.659,196.925,199.33100000000002,201.653,205.389,207.406,209.423,211.743,216.645,220.769,226.911,231.036,233.912,236.78900000000002,239.124,241.141,245.266,247.571,249.977,254.101,257.366,259.646,262.052,264.928,268.664,271.93,276.054,279.319,283.444,287.649,290.526,294.65,298.775,302.04,306.164,308.182,311.918,313.935,316.22,318.626,321.503,324.768,328.033" y="297.751" svg_rhmargin="330.05" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[13] Park CM, Goo JM, Lee HJ, et al. Tumors in the tracheobronchial tree:</text>
  <text x="101.596,106.96,111.862,114.351,118.087,122.211,126.336,128.863,132.988,138.741,144.49400000000003,147.004,151.128,155.641,160.54299999999998,163.047,165.453,168.719,172.454,174.86,178.985,181.861,185.127,188.003,190.01999999999998,192.582,197.947,201.683,205.807,207.824,211.949,215.685,218.561,222.297,226.422,230.546,232.564,235.829,238.70600000000002,241.22,245.345,249.469,253.594,257.718,259.814,263.939,268.064,270.081,274.205" y="306.709" svg_rhmargin="278.329" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">CT and FDG PET features. Radiographics 2009;29:55</text>
  <text x="278.363" y="306.709" svg_rhmargin="282.099" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="282.105,286.231,290.356" y="306.709" svg_rhmargin="292.373" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">71.</text>
  <text svg_rhmargin="266.347" x="85.212,87.618,91.743,95.867,98.27300000000001,101.596,107.35,111.086,115.21,117.227,120.493,122.51,125.387,126.88,132.244,136.757,138.774,140.315,144.827,148.952,154.705,157.97,159.475,164.84,167.717,169.734,171.266,176.632,180.756,184.881,187.757,191.493,192.979,200.451,205.815,207.832,209.361,212.627,215.03300000000002,216.504,220.24,222.258,224.275,225.802,230.703,234.828,238.093,239.577,243.703,246.108,248.126,250.143,252.161,254.567,258.303,259.816,263.941,266.347" y="315.666" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[14] Daniels CE, Lowe VJ, Aubry MC, et al. The utility of </text>
  <text x="267.876" y="315.666" svg_rhmargin="272.0" style="fill:#171615;font-family:HPMFFO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="272.015,276.139,280.264,283.14,287.265,291.389,294.654,298.779,302.903,306.639,310.375,312.392,316.517,319.859,323.984,326.861" y="315.666" svg_rhmargin="330.126" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">uorodeoxyglucose</text>
  <text x="101.597,105.722,109.846,112.723,114.74,117.146,120.023,124.147,128.272,131.699,134.964,141.106,143.123,146.0,148.876,150.894,155.018,159.143,162.594,165.0,169.124,175.266,179.391,183.126,186.003,189.739,193.863,197.988,201.724,205.11,207.127,211.252,214.691,217.097,221.221,224.486,227.9,231.165,234.901,238.637,240.654,244.779,248.514,250.92,252.938,257.062,261.187,264.577,268.702,271.108,274.556,277.821,281.557,284.434,287.699,289.716,293.841,297.965,299.982,304.107,307.492,309.897,314.022,320.164,324.288,327.165" y="324.68" svg_rhmargin="330.042" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">positron emission tomography in the evaluation of carcinoid tumors</text>
  <text x="101.597,105.722,108.598,111.863,114.74,118.005,122.13,124.536,126.553,130.677,134.41299999999998,136.971,140.707,143.584,146.042,150.166,154.291,156.308,162.45,166.574,170.699,174.435,177.39,181.12599999999998,183.626,187.752,191.876,196.0,200.125,202.142,205.407,208.284,210.301,212.822,218.186,222.311,225.576,228.453,230.859,233.4,237.524,241.649,245.773,249.897,251.915,256.039,260.164,264.288,266.306,270.43,274.554" y="333.637" svg_rhmargin="278.678" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">presenting as pulmonary nodules. Chest 2007;131:255</text>
  <text x="278.762" y="333.637" svg_rhmargin="282.498" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="282.447,286.572,290.697" y="333.637" svg_rhmargin="292.714" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">60.</text>
  <text x="85.213,87.619,91.743,95.868,98.274,101.596,105.722,109.458,111.863,114.269,117.535,121.659,125.783,129.049,133.174,135.157,141.381,146.746,148.763,150.746,155.259,158.524,162.649,166.773,170.509,172.458,179.929,181.946,183.909,188.422,191.687,195.811,200.008,204.133,209.88600000000002,211.856,216.369,218.386,220.303,223.568,225.97400000000002,227.957,231.692,233.71,235.727,237.707,242.609,245.874,248.751,251.157,253.127,257.251,260.516,263.393,265.799,269.923,272.8,278.942,282.678,286.802,290.067,293.332,295.36,299.484,301.89,303.863,307.988,312.501,317.402,319.808,325.173" y="342.594" svg_rhmargin="330.075" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[15] Pattenden HA, Leung M, Beddow E, et al. Test performance of PET-CT</text>
  <text x="101.597,104.003,108.128,111.005,114.012,120.155,123.42,127.545,129.562,133.298,136.174,138.58,140.598,144.722,148.458,150.475,153.581,155.599,159.335,165.477,169.601,173.726,176.767,180.892,185.016,189.141,192.40599999999998,195.418,198.294,200.7,204.436,208.172,210.189,214.314,218.04999999999998,221.097,225.222,227.62800000000001,230.678,234.802,238.927,240.944,247.086,251.21,255.335,259.071,261.947,265.683,268.715,271.98,275.716,278.593,281.858,283.875,288.0,292.124,294.225,298.35,301.368,303.774,307.898,314.04,318.164,322.289,325.165,328.042" y="351.551" svg_rhmargin="330.059" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">for mediastinal lymph node staging of pulmonary carcinoid tumours.</text>
  <text x="101.597,106.499,110.623,114.748,117.624,121.36,125.485,128.014,132.138,136.263,140.387,144.511,146.529,150.653,154.778,156.795,160.92,165.044" y="360.508" svg_rhmargin="169.168" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Thorax 2015;70:379</text>
  <text x="169.231" y="360.508" svg_rhmargin="172.967" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text svg_rhmargin="183.184" x="172.916,177.041,181.167,183.184" y="37.75699999999995" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">81. </text>
  <text x="345.205,347.611,351.735,355.86,358.266,361.588,366.953,370.689,374.425,378.161,382.285,384.302,388.742,391.148,393.165,397.529,402.894,407.018,411.143,414.019,417.755,422.189,426.702,432.455,434.472,438.856,444.609,447.486,451.61,455.346,458.611,461.488,465.953,471.318,478.789,480.806,485.17,488.435,490.841,495.261,498.997,501.014,503.031,507.45,512.8149999999999,517.201,520.466,524.591,530.733,534.857,538.593,541.47,543.487,546.364,550.488,554.613,559.037,563.162,565.568,569.978,574.103,578.227,583.981,587.716" y="37.75699999999995" svg_rhmargin="590.122" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[16] Kayani I, Conry BG, Groves AM, et al. A comparison of 68Ga-</text>
  <text x="361.589,367.343,373.486,378.388,383.753,388.746,394.111,399.014,403.527,408.079,411.815,415.94,420.065,424.634,428.759,432.884,437.009,439.416,443.541,449.295,455.048,459.615,463.74,468.254,473.156,475.175,480.54,485.442,490.061,492.079,496.204,500.776,504.901,509.026,511.044,517.187,521.312,525.437,529.174,532.051,535.787,540.35,544.475,547.741,551.867,554.808,558.933,562.199,566.324,570.45,574.575,577.841,580.718,582.736,586.861" y="46.71500000000003" svg_rhmargin="590.126" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine</text>
  <text x="361.589,363.995,368.119,374.261,378.385,381.262,384.139,386.156,388.686,391.563,394.072,400.214,404.339,407.604,409.621,412.157,419.628,422.893,427.018,429.504,433.628,437.753,441.877,446.001,448.019,452.143,456.268,458.358,462.482,466.606,470.731" y="55.672000000000025" svg_rhmargin="474.855" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">tumors. J Nucl Med 2009;50:1927</text>
  <text x="474.861" y="55.672000000000025" svg_rhmargin="478.597" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="478.603,482.728,486.853" y="55.672000000000025" svg_rhmargin="488.87" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">32.</text>
  <text x="345.205,347.611,351.735,355.86,358.266,361.588,366.953,371.077,375.202,379.326,383.062,386.814,390.55,392.567,396.282,400.795,404.06,407.325,411.022,416.387,420.123,422.14,425.875,431.239,433.257,439.399,443.108,447.621,452.523,454.54,458.301,461.566,463.972,467.655,471.391,473.408,475.425,479.163,481.569,485.693,488.099,491.364,495.1,497.977,501.713,504.119,507.384,511.509,515.273,519.398,523.911,528.812,530.83,536.194,541.096,544.808,548.932,551.338,555.069,559.193,563.318,565.335,571.477,575.601,579.726,583.462,586.338" y="64.62900000000002" svg_rhmargin="590.074" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[17] Chong S, Lee KS, Kim BT, et al. Integrated PET/CT of pulmonary</text>
  <text x="361.589,365.713,368.979,373.103,375.98,380.104,383.369,387.494,391.69,395.815,399.08,401.957,403.974,408.099,411.364,412.779,415.185,419.309,425.451,429.575,432.452,435.329,437.346,438.799,442.923,444.94,448.676,452.412,456.537,460.661,463.538,465.944,467.961,471.226,472.698,476.434,480.559,484.684,486.077,490.202,493.079,497.203,500.939,505.064,509.188,512.065,514.471,516.488,519.753,521.224,523.242,529.384,533.508,535.526,537.543,540.808,544.544,546.95,548.967,553.092,557.216,560.093,562.11,563.57,568.935,571.812,577.177,578.593,583.959" y="73.58600000000001" svg_rhmargin="590.101" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">neuroendocrine tumors: diagnostic and prognostic implications. AJR Am</text>
  <text x="361.589,364.466,366.975,372.34,376.465,379.73,383.854,386.26,389.996,393.261,397.385,401.51,403.527,406.09,410.215,414.339,418.463,422.588,424.605,428.73,432.854,436.978,438.996,443.12,447.245,451.369" y="82.543" svg_rhmargin="455.493" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">J Roentgenol 2007;188:1223</text>
  <text x="455.585" y="82.543" svg_rhmargin="459.321" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="459.27,463.395,467.52" y="82.543" svg_rhmargin="469.537" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">31.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,365.324,369.448,371.466,373.483,375.501,379.625,381.642,383.356,390.828,392.84499999999997,394.525,399.038,401.914,406.039,409.775,411.418,415.542,420.907,422.924,424.569,428.694,431.57,435.306,437.712,440.977,443.854,447.979,451.714,453.82,455.837,457.448,462.814,464.831,466.519,469.784,472.19,473.832,477.568,479.586,481.603,483.299,487.424,491.937,496.839,498.492,502.228,506.353,510.478,512.155,516.279,520.792,525.693,527.711,533.076,537.9780000000001,539.648,545.402,547.419,549.825,553.95,555.635,559.76,563.884,567.62,571.356,573.373,575.391,577.408,581.533,587.674" y="91.55700000000002" svg_rhmargin="590.08" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[18] Sollini M, Erba PA, Fraternali A, et al. PET and PET/CT with 68gallium-</text>
  <text x="361.589,363.606,367.342,371.467,374.732,376.749,380.014,384.139,386.929,389.805,393.93,400.072,403.808,406.213,410.338,413.215,415.62,419.356,421.762,423.78,427.905,430.692,434.428,438.552,442.288,444.305,448.43,452.166,456.29,459.555,462.432,465.215,467.233,471.358,474.059,478.183,482.308,486.433,489.195,494.948,499.461,503.586,505.992,512.134,516.646,521.548,524.425,527.176,529.582,533.706,539.848,543.972,546.849,549.726,551.743,554.499,559.401,563.525,566.858,570.594,573.859,575.876,579.142,583.266,585.672,587.689" y="100.51499999999999" svg_rhmargin="590.095" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">labeled somatostatin analogues in non GEP-NETs tumors. TheScienti-</text>
  <text x="361.589" y="109.47199999999998" svg_rhmargin="365.713" style="fill:#171615;font-family:HPMFFO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬁ</text>
  <text x="365.728,368.993,376.465,380.589,383.466,385.483,389.607,392.484,396.608,400.817,403.694,407.818,411.554,413.57099999999997,416.067,420.191,424.315,428.44,432.564,434.582,438.706,442.83,446.955,451.079,453.097,457.221,461.346,465.47,469.594,473.719,477.843" y="109.47199999999998" svg_rhmargin="479.86" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cWorldJournal 2014;2014:194123.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,364.465,366.482,370.607,374.731,378.467,380.484,383.64,388.541,390.558,393.73,399.095,403.219,409.361,413.097,415.974,419.127,424.492,426.509,429.615,434.981,438.246,442.37,446.495,448.512,450.918,454.654,457.619,461.355,467.497,471.233,475.358,478.481,482.994,485.011,488.118,491.383,493.789,496.961,500.697,502.715,504.73199999999997,507.846,512.359,516.094,519.83,521.848,525.972,529.708,532.114,534.131,538.256,542.381,545.543,549.668,552.074,555.237,557.643,561.768,565.033,568.163,571.039,575.164,577.181,580.446,583.582,587.707" y="118.42899999999997" svg_rhmargin="590.113" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[19] Jindal T, Kumar A, Venkitaraman B, et al. Evaluation of the role of</text>
  <text x="361.589,363.995,368.119,372.244,376.368,378.774,382.898,388.652,394.405,396.905,401.029,405.542,410.444,412.461,417.826,422.728,426.44,430.175,434.3,438.425,442.086,444.492,448.617,452.741,458.494,462.23,464.636,470.389,476.531,481.541,486.906,491.807,497.949,503.314,505.72,509.844,514.357,519.259,521.276,526.641,531.543,535.281,537.299,541.424,545.089,549.213,551.23,553.636,556.042,559.308,562.184,565.449,569.574,571.98,573.997,577.733,580.139,582.276,586.4" y="127.38599999999997" svg_rhmargin="590.136" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating</text>
  <text x="361.589,363.995,367.731,371.855,373.873,377.138,380.874,382.891,386.248,389.984,394.108,398.233,401.554,405.29,407.696,411.432,415.556,417.574,420.839,424.575,426.592,429.955,434.08,438.204,440.221,446.363,450.488,454.612,458.348,461.225,464.961,468.276,471.542,475.277,478.154,481.419,483.437,487.561,491.686,493.703,497.827,500.704,502.721,506.087,511.452,515.188,519.313,522.578,525.843,528.7199999999999,532.051,534.456,540.598,544.334,548.07,550.088,554.212,557.948,561.302,565.426,569.551,573.675,577.8,579.817,583.942,588.066" y="136.34299999999996" svg_rhmargin="590.083" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">typical and atypical pulmonary carcinoids. Cancer Imaging 2011;11:</text>
  <text x="361.589,365.713" y="145.35699999999997" svg_rhmargin="369.837" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">70</text>
  <text x="369.866" y="145.35699999999997" svg_rhmargin="373.602" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="373.608,377.732" y="145.35699999999997" svg_rhmargin="379.749" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,366.953,373.095,377.219,380.096,384.22,387.097,389.195,393.319,395.336,397.245,402.61,404.627,406.542,411.907,415.643,418.519,420.925,424.191,426.208,428.225,432.35,435.615,438.88,440.897,442.879,447.003,449.02,450.929,456.294,460.418,464.543,467.808,469.825,471.843,475.968,477.913,483.666,485.683,487.607,490.872,493.278,495.203,498.939,500.957,502.974,504.897,509.022,513.146,518.899,522.635,525.041,530.794,536.936,541.838,547.3,549.706,555.847,561.989,567.354,569.3710000000001,571.336,575.072,576.949,581.074,584.339" y="154.31500000000005" svg_rhmargin="590.092" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[20] Ambrosini V, Castellucci P, Rubello D, et al. 68Ga-DOTA-NOC: a new</text>
  <text x="361.589,365.713,370.226,375.128,377.632,380.038,382.915,386.651,389.916,393.181,396.058,398.55,400.956,405.081,407.958,410.455,413.72,417.456,421.192,423.21,427.334,431.07,433.476,435.493,439.618,443.354,445.886,450.01,453.746,456.152,458.169,461.434,465.559,467.965,470.842,473.38,479.133,481.15,483.556,487.681,490.16,494.284,497.161,501.285,505.41,508.675,512.799,514.817,518.553,520.57,523.095,526.361,530.097,532.973,536.238,538.256,542.38,546.505,548.522,552.647,554.6640000000001,557.222,563.364,567.489,570.754,572.7710000000001,575.25,582.721,585.987" y="163.27200000000005" svg_rhmargin="590.111" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">PET tracer for evaluating patients with bronchial carcinoid. Nucl Med</text>
  <text x="361.589,366.954,371.08,377.222,383.365,387.49,391.615,394.188,398.314,402.439,406.564,410.689,412.707,416.832,420.958,422.976,427.101,431.226" y="172.22900000000004" svg_rhmargin="435.35" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Commun 2009;30:281</text>
  <text x="435.403" y="172.22900000000004" svg_rhmargin="439.139" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="439.145,443.269" y="172.22900000000004" svg_rhmargin="445.286" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">6.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,369.06,373.184,375.202,377.608,379.625,383.749,387.485,389.082,393.206,397.331,399.348,400.873,406.239,410.363,412.769,414.786,418.052,420.92900000000003,422.472,427.837,435.309,437.326,438.855,446.326,449.592,452.468,454.874,460.627,464.752,468.876,473.001,474.568,482.04,486.553,488.57,490.101,493.366,495.772,497.301,501.036,503.054,505.07099999999997,506.598,512.74,518.104,523.469,529.222,534.587,538.323,540.729,544.853,546.87,548.49,552.226,553.706,556.583,559.848,563.584,565.601,568.478,571.743,575.868,577.458,579.864,583.989,588.113" y="181.18600000000004" svg_rhmargin="590.13" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[21] Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool</text>
  <text x="361.589,363.995,368.119,370.99600000000004,372.416,374.822,378.947,382.212,383.64,387.765,391.889,395.625,397.642,399.66,402.066,405.80199999999996,407.223,410.959,413.835,416.712,419.977,422.926,425.802,431.944,435.209,439.334,441.74,443.164,447.288,449.694,451.1,455.225,457.242,460.978,464.714,468.838,472.963,475.839,478.245,480.263,483.52799999999996,485.0,488.736,492.001,495.266,499.39,502.267,506.003,509.268,513.004,514.421,517.297,519.703,523.828,527.952,529.969,533.235,536.111,538.128,539.59,544.955,549.079,553.204,554.613,557.019,561.143,563.549,566.815,569.691,573.816,575.248,582.72,585.985" y="190.14300000000003" svg_rhmargin="590.109" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">for the quality assessment of diagnostic accuracy studies. Ann Intern Med</text>
  <text x="361.589,365.713,369.838,373.962,378.087,380.104,384.228,388.353,392.477,394.581,398.706,402.831" y="199.101" svg_rhmargin="406.955" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2011;155:529</text>
  <text x="406.943" y="199.101" svg_rhmargin="410.679" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="410.685,414.81,418.935" y="199.101" svg_rhmargin="420.952" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">36.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,366.101,370.225,373.491,377.615,380.88,385.005,387.438,391.563,393.58,395.942,400.066,403.331,406.208,410.398,412.803,415.209,417.226,419.581,425.334,427.351,429.785,435.15,438.886,441.763,445.887,447.905,449.922,451.939,456.064,458.47,464.223,466.24,468.617,471.882,474.288,476.724,480.46,482.477,484.49399999999997,486.871,494.343,498.468,500.485,502.891,504.908,508.174,511.439,515.563,517.969,521.234,524.111,526.553,529.819,533.943,540.085,544.209,547.945,550.822,552.839,555.804,559.929,564.054,566.405,570.53,572.9359999999999,575.306,579.43,583.555,587.679" y="208.115" svg_rhmargin="590.085" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[22] Lococo F, Perotti G, Cardillo G, et al. Multicenter comparison of 18F-</text>
  <text x="361.589,365.713,371.467,377.21999999999997,379.73,383.466,387.59,391.715,394.185,398.31,402.434,408.187,411.923,414.329,420.083,426.224,431.126,436.491,438.897,443.021,446.286,450.411,452.816,454.954,459.079,462.344,464.762,468.886,473.399,478.367,480.384,485.749,490.651,493.107,495.513,499.637,502.514,504.955,509.079,513.203,515.221,521.363,525.487,529.612,533.348,536.303,540.039,542.483,545.748,549.484,552.36,555.626,557.643,561.767,565.892,567.992,572.117,574.134,576.553,581.917,583.935,585.952" y="217.072" svg_rhmargin="590.076" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin</text>
  <text x="361.589,367.731,371.855,375.12,377.137,379.673,387.145,390.411,394.536,397.021,401.145,405.27,409.394,413.519,415.614,419.739,423.863,425.881,429.146,433.27,437.395" y="226.029" svg_rhmargin="441.519" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Nucl Med 2015;40:e183</text>
  <text x="441.525" y="226.029" svg_rhmargin="445.261" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="445.267,449.391" y="226.029" svg_rhmargin="451.408" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">9.</text>
  <text x="345.205,347.611,351.735,355.859,358.265,361.588,366.953,370.689,374.425,378.161,382.285,384.302,389.876,392.281,394.298,399.853,404.366,408.491,414.706,418.442,422.566,424.584,426.601,432.166,435.043,439.556,441.573,447.132,452.886,455.763,459.887,463.623,466.888,469.765,475.307,480.672,482.689,488.29,491.555,493.961,499.515,503.25,505.268,507.28499999999997,512.837,516.961,521.086,525.21,528.475,530.881,532.899,537.023,541.148,544.883,546.9000000000001,552.519,554.536,560.678,564.414,568.15,570.167,574.292,578.028,583.584,587.709" y="234.986" svg_rhmargin="590.115" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[23] Kayani I, Bomanji JB, Groves A, et al. Functional imaging of</text>
  <text x="361.589,365.713,368.978,373.103,375.98,380.104,383.369,387.494,391.69,395.815,399.08,401.957,403.974,408.098,411.363,415.216,417.622,421.746,427.888,432.013,434.889,437.766,441.633,447.387,449.405,451.811,455.936,459.832,463.097,467.221,473.363,477.487,479.505,483.629,486.894,491.019,494.922,499.047,503.56,508.461,510.478,515.843,520.745,524.57,528.695,531.571,533.589,537.713,541.449,545.319,549.443,553.568,559.321,563.057,565.463,571.216,577.358,582.259,587.721" y="243.94399999999996" svg_rhmargin="590.127" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">neuroendocrine tumors with combined PET/CT using 68Ga-DOTA-</text>
  <text x="361.589,366.49,371.855,376.757,381.27,383.698,386.104,391.857,395.982,398.387,402.123,404.529,410.283,414.407,418.531,421.797,425.921,427.938,432.959,436.695,439.572,443.696,446.102,450.227,453.492,455.898,458.774,462.04,466.164,468.57,472.306,474.712,477.977,480.383,482.845,486.581,490.705,494.83,497.244,501.368,505.492,509.617,512.023,516.147,521.901,527.654,529.671,532.107,537.472,541.208,545.332,548.597,551.863,554.74,557.163,561.287,565.412,569.536,573.661,575.678,579.803,583.927,588.052" y="252.90099999999995" svg_rhmargin="590.069" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">TATE (Dota-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 2008;112:</text>
  <text x="361.589,365.714,369.839,373.964" y="261.91499999999996" svg_rhmargin="378.088" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">2447</text>
  <text x="378.143" y="261.91499999999996" svg_rhmargin="381.879" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="381.885,386.01,390.136" y="261.91499999999996" svg_rhmargin="392.153" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">55.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,367.731,371.855,375.979,379.715,382.97999999999996,387.099,392.464,397.829,399.846,403.936,406.813,410.549,414.673,416.69,420.815,424.939,427.81600000000003,431.94,437.694,445.165,447.182,451.271,454.148,457.884,462.008,465.744,469.869,473.947,478.848,486.32,488.337,492.427,495.693,498.099,502.235,505.971,507.988,510.005,514.083,519.836,521.854,525.59,528.855,531.731,535.467,538.732,542.857,545.2629999999999,549.4,555.542,559.278,563.402,567.138,570.874,574.139,580.281,583.546,587.671" y="270.87199999999996" svg_rhmargin="590.077" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[24] Okoye CC, Jablons DM, Jahan TM, et al. Divergent management</text>
  <text x="361.59,364.466,366.872,369.749,373.485,375.891,379.156,382.892,385.002,388.267,391.144,394.356,396.762,400.886,403.76300000000003,406.997,409.403,413.139,417.263,419.281,422.546,426.282,428.299,431.544,435.279,438.545,441.421,444.298,448.422,451.29900000000004,454.559,458.295,460.701,464.437,468.561,470.578,473.844,477.58,479.597,482.846,486.112,489.847,492.724,495.989,498.007,502.131,506.256,508.273,512.398,515.669,518.075,522.2,528.341,532.466,535.343,538.2199999999999,541.463,545.588,547.9939999999999,551.214,553.62,557.745,561.01,564.253,566.659,570.784,574.908,577.785,581.521,584.786,586.803" y="279.82899999999995" svg_rhmargin="590.068" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">strategies for typical versus atypical carcinoid tumors of the thoracic</text>
  <text x="361.59,364.855,368.591,372.327,374.344,376.75,380.486,382.503,385.059,390.423,396.565,399.061,401.938,404.447,409.813,411.83,413.847,417.972,420.491,426.633,430.758,434.023,438.147,440.164,442.713,446.838,450.962,455.086,459.211,461.228,465.353,469.477,471.494,475.619,479.743" y="288.786" svg_rhmargin="483.867" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">cavity. Am J Clin Oncol 2014;37:350</text>
  <text x="483.932" y="288.786" svg_rhmargin="487.668" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="487.674,491.799" y="288.786" svg_rhmargin="493.816" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="345.205,347.611,351.736,355.86,358.266,361.589,369.061,372.797,378.938,382.204,386.328,389.59299999999996,391.803,399.275,401.292,403.425,409.649,411.666,415.402,419.138,422.015,426.214,428.231,430.353,435.255,437.272,439.48,444.846,446.863,449.269,453.005,455.022,458.287,462.412,464.429,466.635,474.107,476.124,478.257,481.522,483.928,486.08,489.816,491.833,493.85,496.057" y="297.744" svg_rhmargin="498.463" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[25] Mamede M, Higashi T, Kitaichi M, et al. [</text>
  <text x="498.444,501.537" y="294.469" svg_rhmargin="504.63" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:4.98px;font-style:NORMAL;font-weight:normal;">18</text>
  <text x="504.624,508.749,511.155,515.281,521.035,526.788,529.002,533.128,537.253,539.659,543.396,547.521,550.786,552.929,556.665,560.79,564.915,567.102,571.227,576.593,582.735,588.101" y="297.758" svg_rhmargin="590.118" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">F]FDG uptake and PCNA,</text>
  <text x="361.588,367.341,369.359,373.483,375.889,378.295,382.506,384.52299999999997,388.685,392.421,396.545,400.67,404.842,408.966,412.232,416.356,420.48,424.605,426.622,430.747,434.483,437.359,440.624,443.03,445.436,447.842,452.063,455.328,459.453,463.577,466.454,469.719,472.595,475.472,477.49,481.614,485.738,488.615,492.822,494.839,498.964,503.139,506.405,510.141,514.265,517.53,520.795,523.672,526.549,530.747,534.483,538.607,542.732,546.904,548.922" y="306.715" svg_rhmargin="553.046" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">Glut-1, and hexokinase-II expressions in cancers and in</text>
  <text x="553.039" y="306.715" svg_rhmargin="557.163" style="fill:#171615;font-family:HPMFFO+AdvOTbc475f09+fb;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ﬂ</text>
  <text x="557.177,560.913,567.055,573.197,576.933,579.339,583.463,586.428" y="306.715" svg_rhmargin="590.164" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">ammatory</text>
  <text x="361.588,363.605,366.87,369.747,371.764,375.889,380.013,382.89,385.453,389.578,391.984,394.467,396.873,400.998,404.263,406.769,408.786,412.911,417.035,420.771,422.788,425.307,431.448,434.714,438.838,442.962,444.98,448.716,451.592,453.61,457.346,459.886,464.01,468.135,472.259,476.384,478.401,482.525,484.543,488.74,492.864" y="315.672" svg_rhmargin="496.988" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">lesions of the lung. Neoplasia 2005;7:369</text>
  <text x="496.969" y="315.672" svg_rhmargin="500.705" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="500.711,504.836,508.962" y="315.672" svg_rhmargin="510.979" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">79.</text>
  <text x="345.204,347.61,351.734,355.858,358.264,361.587,367.729,370.994,375.118,379.243,383.367,387.103,391.228,396.11,398.516,404.74,406.757,411.587,415.323,419.447,421.464,423.482,427.607,432.392,437.757,439.774,444.637,449.538,453.274,457.01,461.134,464.011,467.747,472.527,476.652,478.669,483.525,486.79,489.196,494.013,497.749,499.767,501.784,506.599,512.352,514.37,518.494,521.759,525.884,528.76,532.025,536.871,539.277,542.154,545.889,550.014,552.891,557.015,561.139,564.016,566.422,569.687,572.564,574.97,579.095,583.979,585.997" y="324.686" svg_rhmargin="590.121" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[26] Ozbudak IH, Shilo K, Tavora F, et al. Glucose transporter-1 in</text>
  <text x="361.588,365.712,369.837,371.854,377.996,382.12,386.245,389.981,392.936,396.67199999999997,399.116,403.24,406.505,410.63,413.506,417.631,420.896,425.02,429.217,433.342,436.607,439.483,441.501,445.625,448.89,451.382,454.647,458.383,461.26,464.525,466.543,470.667,474.791,480.933,484.669,487.546,489.563,492.084,495.349,499.474,503.598,506.475,509.74,512.617,515.493,517.511,521.635,525.76,528.251,531.987,536.112,540.237,542.707,545.584,549.708,552.585,556.321,558.338,562.074,565.81,567.827,570.314,574.05,578.174,581.91,583.928,587.664" y="333.643" svg_rhmargin="590.07" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">pulmonary neuroendocrine carcinomas: expression and survival analy-</text>
  <text x="361.588,364.464,366.482,369.359,371.376,373.889,381.361,385.486,389.611,392.143,396.267,400.003,402.409,406.534,410.658,412.675,415.215,419.34,423.465,427.589,431.714,433.731,437.855,441.98,443.997,448.122,452.246" y="342.6" svg_rhmargin="456.37" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">sis. Mod Pathol 2009;22:633</text>
  <text x="456.435" y="342.6" svg_rhmargin="460.171" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="460.177,464.301" y="342.6" svg_rhmargin="466.318" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">8.</text>
  <text x="345.204,347.61,351.735,355.859,358.265,361.588,366.953,368.97,373.094,375.111,378.708,384.073,386.09,389.649,395.402,399.527,403.651,405.668,408.545,412.281,415.896,423.368,425.385,428.934,435.158,438.894,443.018,445.424,449.549,453.673,456.55,458.956,464.321,468.056,472.181,476.305,480.123,484.248,487.777,491.513,493.53,497.074,500.339,502.745,506.314,510.05,512.068,514.085,517.652,520.058,522.464,528.606,532.342,536.078,538.095,542.311,546.047,549.568,553.692,556.098,559.659,563.783,566.66,570.784,574.909,578.174,582.298,584.316,588.052" y="351.557" svg_rhmargin="590.069" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">[27] Zidi A, Douira W, Hantous-Zannad S, et al. [Imaging of bronchial</text>
  <text x="361.589,364.854,368.59,371.466,374.731,376.749,380.873,384.998,387.098,391.223,393.675,396.081,400.205,406.347,410.471,413.348,416.225,418.242,420.829,424.953,429.078,431.543,434.808,438.544,441.421,444.686,447.563,449.969,451.986,454.559,459.923,463.189,466.925,469.411,473.535,477.66,480.925,485.049,491.191,495.316,497.33299999999997,499.853,505.217,507.235,509.252,513.377,515.896,520.021,524.145,528.269,532.394,534.411,538.536,542.66,544.75,548.874,552.999" y="360.515" svg_rhmargin="557.123" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">carcinoid tumors: 20 cases]. Rev Pneumol Clin 2006;62:380</text>
  <text x="557.121" y="360.515" svg_rhmargin="560.857" style="fill:#171615;font-family:HPMFFN+AdvOTbc475f09+20;font-size:7.47px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="560.863,564.987" y="360.515" svg_rhmargin="567.004" style="fill:#171615;font-family:HPMFFM+AdvOTbc475f09;font-size:7.47px;font-style:NORMAL;font-weight:normal;">5.</text>
  <text x="85.039,89.024,90.435,94.5,98.732,103.131,105.732,109.796,112.11500000000001,114.746,118.811,120.221,122.373,125.064,131.616,135.68,140.239,141.65,145.715,147.126,151.358,155.423,158.002,159.907,164.306,168.706,173.105,177.505,179.41,182.038,186.438,190.837,192.989,197.389,201.788,517.041,522.931,528.821,534.711,536.863,543.414,547.973,550.874,552.285,556.685,560.917,563.3,567.532,571.597,573.008,575.16,579.224,583.624" y="9.870999999999981" svg_rhmargin="590.176" style="fill:#171615;font-family:HPMFEF+AdvOT6e5d2ec0;font-size:7.97px;font-style:NORMAL;font-weight:normal;">Jiang et al. Medicine (2019) 98:10 www.md-journal.com</text>
  <text x="335.396" y="739.625" svg_rhmargin="339.796" style="fill:#171615;font-family:HPMFPB+AdvOTf94803d4;font-size:7.97px;font-style:NORMAL;font-weight:normal;">7</text>
 </g>
</svg>
